Lorigerlimab
Product Specifications
CAS Number
2416595-46-3
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis
Bioactivity
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting (DART) antibody that inhibits PD-1 and CTLA-4 to enhance T-cell responses, currently being investigated for metastatic castration-resistant prostate cancer (mCRPC) [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15392836 1 Vial
Lentiviral human ME1 sgRNA gene knockout kit - Lentiviral human ME1 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details MBS1344502-01 0.02 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Rhamnulose-1-phosphate aldolase (rhaD)
Sign In for Pricing
View Details 
MBS1344502-02 0.02 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Rhamnulose-1-phosphate aldolase (rhaD)
Sign In for Pricing
View Details MBS1344502-03 0.1 mg (E-Coli)
Recombinant Yersinia pestis bv. Antiqua Rhamnulose-1-phosphate aldolase (rhaD)
Sign In for Pricing
View Details MBS1344502-04 0.1 mg (Yeast)
Recombinant Yersinia pestis bv. Antiqua Rhamnulose-1-phosphate aldolase (rhaD)
Sign In for Pricing
View Details 
MBS1344502-05 0.02 mg (Baculovirus)
Recombinant Yersinia pestis bv. Antiqua Rhamnulose-1-phosphate aldolase (rhaD)
Sign In for Pricing
View Details